Literature DB >> 25068421

Improvement of high serum levels of biomarkers of endothelial injury after allogeneic hematopoietic SCT with pre-existing severe hepatitis using recombinant human soluble thrombomodulin.

T Saito1, Y Inoue1, K Sato1, Y Tsuruoka1, R Shigefuku2, H Ikeda2, C Okuse2, M Takahashi1, I Miura1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25068421     DOI： 10.1038/bmt.2014.156

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  9 in total

1.  Vascular endothelial lesion in patients undergoing bone marrow transplantation.

Authors:  S Richard; M Seigneur; A Blann; R Adams; M Renard; M Puntous; J M Boiron; J Amiral; J Reiffers; M Boisseau
Journal:  Bone Marrow Transplant       Date:  1996-11       Impact factor: 5.483

2.  Successful treatment of sinusoidal obstructive syndrome after hematopoietic stem cell transplantation with recombinant human soluble thrombomodulin.

Authors:  T Ikezoe; K Togitani; N Komatsu; M Isaka; A Yokoyama
Journal:  Bone Marrow Transplant       Date:  2009-08-31       Impact factor: 5.483

3.  Can recombinant thrombomodulin play a preventive role for veno-occlusive disease after haematopoietic stem cell transplantation?

Authors:  S Nomura; R Ozasa; T Nakanishi; S Fujita; M Miyaji; S Mori; T Yokoi; T Ito; K Ishii
Journal:  Thromb Haemost       Date:  2011-04-07       Impact factor: 5.249

Review 4.  The role of the endothelium in the short-term complications of hematopoietic SCT.

Authors:  E Carreras; M Diaz-Ricart
Journal:  Bone Marrow Transplant       Date:  2011-04-04       Impact factor: 5.483

5.  Efficacy and safety of recombinant human soluble thrombomodulin (ART-123) in disseminated intravascular coagulation: results of a phase III, randomized, double-blind clinical trial.

Authors:  H Saito; I Maruyama; S Shimazaki; Y Yamamoto; N Aikawa; R Ohno; A Hirayama; T Matsuda; H Asakura; M Nakashima; N Aoki
Journal:  J Thromb Haemost       Date:  2006-10-13       Impact factor: 5.824

6.  Prediction of veno-occlusive disease using biomarkers of endothelial injury.

Authors:  Corey Cutler; Haesook T Kim; Shaké Ayanian; Gary Bradwin; Carolyn Revta; Julie Aldridge; Vincent Ho; Edwin Alyea; John Koreth; Philippe Armand; Robert Soiffer; Jerome Ritz; Paul G Richardson; Joseph H Antin
Journal:  Biol Blood Marrow Transplant       Date:  2010-02-23       Impact factor: 5.742

7.  The syndrome of hepatic veno-occlusive disease after marrow transplantation.

Authors:  S I Bearman
Journal:  Blood       Date:  1995-06-01       Impact factor: 22.113

8.  Venocclusive disease of the liver after bone marrow transplantation: diagnosis, incidence, and predisposing factors.

Authors:  G B McDonald; P Sharma; D E Matthews; H M Shulman; E D Thomas
Journal:  Hepatology       Date:  1984 Jan-Feb       Impact factor: 17.425

9.  Activated protein C blocks p53-mediated apoptosis in ischemic human brain endothelium and is neuroprotective.

Authors:  Tong Cheng; Dong Liu; John H Griffin; José A Fernández; Francis Castellino; Elliot D Rosen; Kenji Fukudome; Berislav V Zlokovic
Journal:  Nat Med       Date:  2003-02-03       Impact factor: 53.440
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.